Company Overview of REN Pharmaceuticals, Inc.
REN Pharmaceuticals, Inc. develops and markets therapeutics for renal and associated cardio-renal diseases. The company offers data and useful reagents, including antibodies and recombinant proteins for studying the biology of renalase. Its products are used in the prevention and treatment of kidney disease and associated comorbid conditions. REN Pharmaceuticals, Inc. was founded in 2006 and is based in South San Francisco, California.
270 East Grand Avenue
South San Francisco, CA 94080
Founded in 2006
Key Executives for REN Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Novartis Vaccines and Diagnostics, Inc.||United States|
|Chartwell Pharmaceuticals LLC||United States|
|Enhance Biotech Inc.||United States|
|TesoRx LLC||United States|
|ARIIX Holdings, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact REN Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.